MARKET

AMPH

AMPH

Amphastar Pharma
NASDAQ
29.26
+0.63
+2.20%
After Hours: 28.95 -0.31 -1.06% 18:43 02/06 EST
OPEN
28.61
PREV CLOSE
28.63
HIGH
29.46
LOW
28.61
VOLUME
343.84K
TURNOVER
--
52 WEEK HIGH
34.39
52 WEEK LOW
20.39
MARKET CAP
1.34B
P/E (TTM)
12.97
1D
5D
1M
3M
1Y
5Y
1D
Is Amphastar (AMPH) Turning Margin Compression Into a Test of Its Operational Discipline?
Simply Wall St · 3d ago
Weekly Report: what happened at AMPH last week (0126-0130)?
Weekly Report · 6d ago
Weekly Report: what happened at AMPH last week (0119-0123)?
Weekly Report · 01/26 10:01
Amphastar Pharmaceuticals (AMPH) Gets a Hold from Bank of America Securities
TipRanks · 01/20 11:56
Weekly Report: what happened at AMPH last week (0112-0116)?
Weekly Report · 01/19 10:05
A Look At Amphastar Pharmaceuticals (AMPH) Valuation After The AMP-110 License Agreement With Nanjing Hanxin
Simply Wall St · 01/15 16:20
Why Amphastar Pharmaceuticals (AMPH) Stock Is Nosediving
Barchart · 01/15 15:04
Trump admin rolls back $2B in mental health, addiction grant cuts—report
Seeking Alpha · 01/15 11:49
More
About AMPH
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable, inhalation, and intranasal products. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers. The Company manufactures and sells over 25 products, such as BAQSIMI (glucagon) nasal powder 3mg, Primatene MIST, Glucagon for Injection Emergency Kit, Enoxaparin, Naloxone and Other Marketed Products, including Cortrosyn (cosyntropin for injection), Amphadase, Epinephrine injection, Lidocaine jelly, Lidocaine topical solution, Phytonadione injection, and others. The Company manufactures and sells two API products, Recombinant Human Insulin (RHI API) and porcine insulin API, for the injectable insulin market.

Webull offers Amphastar Pharmaceuticals Inc stock information, including NASDAQ: AMPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMPH stock methods without spending real money on the virtual paper trading platform.